Mepsevii Prices, Coupons and Patient Assistance Programs
Mepsevii (vestronidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Mucopolysaccharidosis Type VII.
This Mepsevii price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Mepsevii intravenous solution (2 mg/mL) is around $2,273 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Mepsevii Coupons and Rebates
Mepsevii offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Mepsevii UltraCare Copay Assistance Program: Eligible patients may be able to receive financial assistance to cover for out-of-pockets costs off your prescriptions; for additional information contact the program at 888-756-8657.
|Number of uses:||Per prescription until program expires|
Patient Assistance Programs for Mepsevii
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: UltraCare Patient Assistance Program
- Determined case by case
- No limits
- FDA-approved diagnosis
- US residency requirements are not specified.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Mepsevii (vestronidase alfa-vjbk) Injection; IV
More about Mepsevii (vestronidase alfa)
- Side Effects
- During Pregnancy
- Dosage Information
- En Español
- Drug class: lysosomal enzymes
- FDA Approval History